ORTOSTATIChESKAYa GIPOTENZIYa I GIPERTENZIYa POKOYa PRI SINUKLEINOPATIYaKh
I V Litvinenko , P S Dynin
Russian Military Medical Academy Reports ›› 2019, Vol. 38 ›› Issue (3 (Прил)) : 86 -88.
ORTOSTATIChESKAYa GIPOTENZIYa I GIPERTENZIYa POKOYa PRI SINUKLEINOPATIYaKh
| [1] |
Jellinger K.A., Wenning G.K. Multiple system atrophy: pathogenic mechanisms and biomarkers. J. Neural Transm. 2016 Jun,123(6): P. 555-572. doi: 10.1007/s00702-016-1545-2. |
| [2] |
Low P.A., Tomalia V.A. Orthostatic Hypotension: Mechanisms, Causes, Management. Journal of clinical neurology, 2015, 11(3), P. 220-226. doi:10.3988/jcn.2015.11.3.220. |
| [3] |
Palma J-A., Kaufmann H. Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension. Mov Disord Clin Pract. 2017 May-Jun,4(3): P. 298-308. doi: 10.1002/mdc3.12478. |
| [4] |
Palma J-A. Autonomic dysfunction in Parkinson’s disease and other synucleinopathies: introduction to the series. Mov Disord. 2018: 33: P. 347-348. doi: 10.1002/mds.27347. |
| [5] |
Ma L.Y., Liu G.L., Wang D.X. et al. Alpha-Synuclein in Peripheral Tissues in Parkinson’s Disease. ACS Chem Neurosci. 2019 Feb 20,10(2): P. 812-823. doi: 10.1021/acschemneuro.8b00383. |
| [6] |
Espay A.J., LeWitt P.A., Hauser R.A. et al. Neurogenic orthostatic hypotension and supine hypertension in Parkinson’s disease and related synucleinopathies: prioritisation of treatment targets. The Lancet Neurology. Lancet Neurol. 2016 Aug,15(9): P. 954-966. doi: 10.1016/S1474-4422(16)30079-5. |
| [7] |
Palma J.-A., Kaufmann H. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies. Mov Disord. 2018,33(3):372-390. doi:10.1002/mds.27344. |
Litvinenko I.V., Dynin P.S.
/
| 〈 |
|
〉 |
PDF
